April 8, 2024
Brian Bloom, Chairman and Chief Executive Officer of Bloom Burton & Co. comments in the following Globe and Mail coverage on the development of psychedelics in Canadian healthcare, including by companies such as Cybin (NYSE: CYBN / NEO: CYBN).